Records containing: Pemphigus Vulgaris
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-30Prevalence and Clinical Severity of Autoimmune Blistering Diseases
-
CLINICAL_TRIALS study record update · 2026-03-10Effect of Topical Insulin on Healing Rate of Pemphigus Lesions
-
CLINICAL_TRIALS study record update · 2025-12-17A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris
-
CLINICAL_TRIALS study record update · 2025-08-22Booster Effects With Autoimmune Treatments in Patients With Poor Response to Initial COVID-19 Vaccine (ACV01)
-
CLINICAL_TRIALS study record update · 2025-05-14EFFECT OF LOW LEVEL LASER THERAPY ON ORAL PIMPHIGUS VULGARIS
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-03-30An Open-Label, Multicenter, Follow-up Trial of ARGX-113-1904 to Evaluate the Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Patients With Pemphigus
-
CLINICAL_TRIALS study record update · 2025-02-28Comparison of Successful Treatment Outcomes of Dexamethasone Cyclophosphamide Pulse (DCP) Therapy and Dexamethasone Azathioprine Pulse (DAP) Therapy in Pemphigus Vulgaris Patients At a Tertiary Care Hospital, Karachi
-
CLINICAL_TRIALS study record update · 2024-10-01A Randomized, Double-Blinded, Placebo-Controlled Trial to Investigate the Efficacy, Safety, and Tolerability of Efgartigimod PH20 SC in Adult Patients With Pemphigus (Vulgaris or Foliaceus)
-
CLINICAL_TRIALS study record update · 2024-09-03Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
-
CLINICAL_TRIALS study record update · 2024-05-07A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
-
CLINICAL_TRIALS study record update · 2023-12-15Dexamethasone Solution and Dexamethasone in Mucolox™ for the Treatment of Oral Inflammatory Ulcerative Diseases
-
CLINICAL_TRIALS study record update · 2023-12-12Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients: A Retrospective Study
-
CLINICAL_TRIALS study record update · 2023-03-01Evaluation of the Relationship of Tzanck Smear Findings And Disease Activity In Patients With Pemphigus Vulgaris
-
CLINICAL_TRIALS study record update · 2023-02-13An Open-Label, Phase 2, Pilot Study Investigating the Safety, Clinical Activity, Pharmacokinetics, and Pharmacodynamics of Oral Treatment With the BTK Inhibitor PRN1008 in Patients With Newly Diagnosed or Relapsing Pemphigus Vulgaris
-
CLINICAL_TRIALS study record update · 2022-11-08Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid Compared to Conventional Topical Treatment
-
CLINICAL_TRIALS study record update · 2022-08-10Comparative Analysis of the Th17 Cellular Response in Active and Inactive Pemphigus Vulgaris Patients
-
CLINICAL_TRIALS study record update · 2022-03-31A Crossover, Randomized and Multi-center Study to Evaluate the Efficacy and Safety of Abatacept Versus Mycophenolate Mofetil (MMF) in Treatment of PV
-
CLINICAL_TRIALS study record update · 2021-11-22A Phase I, Open-Label, Multicenter Trial Exploring the Safety and Tolerability of Autologous Polyclonal Regulatory T Cell Therapy in Adults With Active Pemphigus (APG01)
-
CLINICAL_TRIALS study record update · 2021-02-02Short-term Efficacy of Interleukin-2 Gargle Combined With Systemic Use of Glucocorticoids in the Treatment of Oral Mucosal Lesion in Pemphigus Vulgaris: a Randomized, Controlled, Double-blind, Multicenter Clinical Study
-
CLINICAL_TRIALS study record update · 2021-01-08Phenotypic and Functional Characterisation of Human B-cell Response in Pemphigus and Application to Other Auto-immune Diseases
-
CLINICAL_TRIALS study record update · 2020-12-14An Open-label, Non-controlled, Phase II Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, Efficacy and Conditions of Use of ARGX-113 in Patients With Mild to Moderate Pemphigus (Vulgaris and Foliaceus)
-
CLINICAL_TRIALS study record update · 2020-10-19A Randomized, Partial-blind, Placebo-controlled Trial Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of VAY736 in the Treatment of Patients With Pemphigus Vulgaris
-
CLINICAL_TRIALS study record update · 2020-02-05A Phase 1B/2, Multicenter, Open-Label, Safety, and Dose-Finding Study of SYNT001 in Subjects With Pemphigus (Vulgaris or Foliaceus)
-
CLINICAL_TRIALS study record update · 2020-01-18A Randomized, Double-Blind, Double-Dummy, Active-Comparator, Multicenter Study to Evaluate the Efficacy and Safety of Rituximab Versus MMF in Patients With Pemphigus Vulgaris
-
CLINICAL_TRIALS study record update · 2019-09-13A Phase 2 Dose-Escalation Study of the Safety and Tolerability of INCB050465 in Participants With Pemphigus Vulgaris